THE DIGITAL GENESIS: ASSESSING THE CONVERGENCE OF ARTIFICIAL INTELLIGENCE AND ASSISTED REPRODUCTIVE TECHNOLOGY (ART)

Abstract

Motivation and Purpose: Infertility has emerged as a significant global health challenge, affecting approximately 17.5% of the adult population, or roughly one in six individuals worldwide. While Assisted Reproductive Technology (ART), specifically In Vitro Fertilization (IVF), has provided a beacon of hope since its inception in 1978, the procedure remains characterized by inconsistent success rates, high emotional and physical toll, and staggering financial costs. The primary limitation in contemporary ART is the subjectivity inherent in manual embryo grading—an "art" performed by human embryologists that is prone to intra-observer variability. The purpose of this research is to investigate the convergence of Artificial Intelligence (AI) and clinical embryology to transform IVF from a subjective practice into a data-driven, precise science. By integrating concepts from Class XII Biology (Human Reproduction and Genetics) and Computer Science (Neural Networks and Data Structures), this study aims to evaluate how deep learning models can optimize embryo selection, predict maternal risks like OHSS, and mitigate the socio-economic barriers to fertility care. Research Methods and Results: This investigative project utilizes a multi-disciplinary meta-analysis approach, synthesizing data from 50+ authoritative sources, including the CDC, ASRM, and recent clinical studies from MDPI and PubMed. The computational aspect focuses on the application of Convolutional Neural Networks (CNNs) and Vision Transformers (ViTs) in analyzing morphokinetic data from Time-Lapse Monitoring (TLM) systems. By processing millions of image patches, these models identify subtle developmental markers—such as the exact timing of the third cleavage or cytoplasmic streaming patterns—that are invisible to the human eye. Results from clinical datasets indicate that AI-integrated selection achieves an Area Under the Curve (AUC) for implantation prediction between 0.70 and 0.93, significantly outperforming traditional static grading scales. Furthermore, data analysis of global economic trends reveals a massive disparity in IVF access, with US costs being 271% higher than the global mean, emphasizing the role of AI in improving the "Single Embryo Transfer" (SET) success rate to reduce unnecessary cycle repetitions and associated costs. Conclusions and Future Plan: The "Digital Genesis" of human reproduction demonstrates that the synergy between PCMB and CS is not merely elective but essential for the advancement of reproductive medicine. The study concludes that while AI significantly enhances precision and reduces iatrogenic risks like Ovarian Hyperstimulation Syndrome (OHSS), its implementation is currently hindered by the "Black Box" nature of algorithms and shifting legal landscapes, such as the 2024 Alabama ruling regarding embryo personhood. The future plan for this research involves exploring Federated Learning—a decentralized machine learning technique—to train global AI models on diverse patient data without compromising HIPAA privacy standards. Additionally, there is a pressing need for legislative frameworks that accommodate technological progress while addressing the ethical concerns of preimplantation genetic testing. Ultimately, the goal is to create a "Human-AI Partnership" that ensures equitable, safe, and highly effective fertility solutions for the next generation

Keywords

Applied Science - Applied Biological Science

Citation

References

Reference metadata is pending and must be finalized before DOI deposit.